Historical shareholding details of Orbimed Advisors, LLC holdings in ARS Pharmaceuticals Inc (SPRY)

Monthly changes of Orbimed Advisors, LLC shareholding in ARS Pharmaceuticals Inc over the previous months

Month Name Total no. shares held Percent Holding
Jun 30, 2025 Orbimed Advisors, Llc 8,288,510 8.39%
Mar 31, 2025 Orbimed Advisors, Llc 8,288,510 8.39%
Dec 31, 2024 Orbimed Advisors, Llc 8,288,510 8.44%
Sep 30, 2024 Orbimed Advisors, Llc 8,288,510 8.53%
Jun 30, 2024 Orbimed Advisors, Llc 9,240,887 9.51%
Mar 31, 2024 Orbimed Advisors, Llc 9,240,887 9.53%
Dec 31, 2023 Orbimed Advisors, Llc 9,240,887 9.58%
Sep 30, 2023 Orbimed Advisors, Llc 9,240,887 9.63%
Jun 30, 2023 Orbimed Advisors, Llc 8,740,887 9.15%
Mar 31, 2023 Orbimed Advisors, Llc 8,740,887 9.15%
Dec 31, 2022 Orbimed Advisors, Llc 8,740,887 9.22%

View all ownership details of ARS Pharmaceuticals Inc